The present invention is directed to a compound having the general structure of formula (1): ##STR00001## useful for the treatment, prevention or amelioration of a CXCR1 or CXCR2 chemokine-mediated disease.

 
Web www.patentalert.com

< 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives

> Substituted cyclopentanes or cyclopentanones as therapeutic agents
~ 00411